Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
30.4%
% of XDNA's 23 holdings also in ARKG
19.4%
% of ARKG's 38 holdings also in XDNA
Overlap by Weight
Sector Drift (XDNA minus ARKG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XDNA |
Weight in ARKG |
Overlap | |
|---|---|---|---|---|
 |
CRISPR THERAPEUTICS AG | 15.1% | 7.0% | 7.0% |
|
INTELLIA THERAPEUTICS, INC. | 8.7% | 4.8% | 4.8% |
|
BEAM THERAPEUTICS, INC. | 13.7% | 4.0% | 4.0% |
|
VERTEX PHARMACEUTICALS INC | 1.5% | 2.7% | 1.5% |
|
REGENERON PHARMACEUTICALS | 1.3% | 1.2% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to ARKG
|
BEAM THERAPEUTICS, INC. | 9.7% |
|
THERMO FISHER SCIENTIFIC INC | 9.5% |
|
CRISPR THERAPEUTICS AG | 8.2% |
|
EDITAS MEDICINE, INC. | 5.7% |
|
PRIME MEDICINE, INC. | 4.7% |
|
CARIBOU BIOSCIENCES, INC. | 4.7% |
|
POSEIDA THERAPEUTICS, INC. | 4.1% |
|
INTELLIA THERAPEUTICS, INC. | 3.9% |
|
ABBVIE INC | 3.8% |
|
ALLOGENE THERAPEUTICS, INC. | 3.4% |
XDNA Underweight Relative to ARKG
|
TWIST BIOSCIENCE CORP. | -10.0% |
|
CAREDX, INC. | -7.4% |
|
RECURSION PHARMACEUTICALS, INC CLASS | -5.4% |
|
IONIS PHARMACEUTICALS, INC. | -4.7% |
|
SCHRODINGER, INC. | -3.8% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | -3.5% |
|
NURIX THERAPEUTICS, INC. | -3.5% |
 |
ALCOBRA LTD | -3.4% |
|
VERACYTE INC | -3.3% |
|
MODERNA, INC. | -3.1% |